Eris Lifesciences Ltd.

NSE: ERIS | BSE: 540596 | ISIN: INE406M01024 | Industry: Pharmaceuticals
| Mid-range Performer
1618.0000 -9.90 (-0.61%)
NSE Jun 26, 2025 15:31 PM
Volume: 75,791
 

logo
Eris Lifesciences Ltd.
18 May 2023
1618.00
-0.61%
buy
by BOB Capital Markets Ltd.
Target: 800
BOB Capital Markets Ltd.
Consolidated Q4 revenue/EBITDA growth of 32%/23% YoY missed consensus by 3%/10%
 
Number of FII/FPI investors increased from 172 to 178 in Mar 2025 qtr.
More from Eris Lifesciences Ltd.
Recommended
Market closes higher, Tata Steel's board approves a $2.5 bn investment in its arm during FY26
Trendlyne Marketwatch | 26 Jun 2025, 04:05PM
Smallcaps are back on the radar, with promising growth | Screener: Analyst favourites among smallcaps
The Baseline | 26 Jun 2025, 12:56PM
Earnings Call Transcript - Q1FY21 for Eris Lifesciences
| 04 Aug 2020